logo

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Twist Bioscience Corporation


USPTO Granted Patents = 76



Trademarks = 1

Forward Citations = 1,202

Loading Chart...
Loading Chart...

41 inventors (with patents filed for the assignee):

goldMedal Bill James Peck (37 out of 37 patents)

silverMedal Siyuan Chen (36 out of 41 patents)

bronzeMedal Pierre F Indermuhle (27 out of 51 patents)

4.  Andres Fernandez (26 out of 42 patents)

5.  William Banyai (23 out of 26 patents)

6.  Aaron Sato (16 out of 80 patents)

7.  Qiang Liu (12 out of 32 patents)

8.  Eugene P Marsh (11 out of 207 patents)

9.  Anthony Cox (6 out of 14 patents)

10.  Pankaj Garg (6 out of 6 patents)

11.  Rebecca Nugent (5 out of 5 patents)

12.  Nathan Raynard (5 out of 5 patents)

13.  Fumiko Takada Axelrod (5 out of 24 patents)

14.  Tom Yuan (5 out of 5 patents)

15.  Sebastian Treusch (4 out of 6 patents)


Core Competencies:
Nucleic Acid Synthesis
Gene Libraries
Antibody Optimization
Polynucleotides
Covalently Closed Nucleic Acids
Digital Information Storage
Hybridization Methods
Seamless Assembly
CRTH2 Variants
GLP1R Antibodies
SARS-CoV-2 Antibodies
Functionalized Surfaces

76 patents:

1. 12742194 - Methods and compositions for high throughput sample preparation using double unique dual indexing (2026-09-22),
2. 12716093 - Methods and compositions relating to continuous sequencing (2026-08-25),
3. 12697597 - Methods for polynucleotide synthesis (2026-08-04),
4. 12644115 - METHYLATION-MEDIATED ADAPTER REMOVAL ON NUCLEIC ACID SEQUENCES (2026-06-02),
5. 12571024 - METHODS AND COMPOSITIONS RELATING TO COVALENTLY CLOSED NUCLEIC ACIDS (2026-03-10),
6. 12570750 - ANTIBODIES THAT BIND ADENOSINE A2A RECEPTORS AND METHODS OF USE THEREOF TO TREAT CANCER AND NEUROLOGICAL DISEASES (2026-03-10),
7. 12569822 - DE NOVO SYNTHESIZED GENE LIBRARIES (2026-03-10),
8. 12565715 - VARIANT NUCLEIC ACID LIBRARIES FOR ANTIBODY OPTIMIZATION (2026-03-03),
9. 12553151 - VARIANT NUCLEIC ACID LIBRARIES FOR GLYCANS (2026-02-17),
10. 12534494 - DEVICES AND METHODS FOR SYNTHESIS (2026-01-27),
11. 12522868 - POLYNUCLEOTIDES, REAGENTS, AND METHODS FOR NUCLEIC ACID HYBRIDIZATION (2026-01-13),
12. 12391762 - Methods and compositions relating to GLP1R variants (2025-08-19),
13. 12357959 - Highly accurate de novo polynucleotide synthesis (2025-07-15),
14. 12331427 - Antibodies that bind GLP1R (2025-06-17),
15. 12325739 - Bispecific SARS-CoV-2 antibodies and methods of use (2025-06-10),
Company Overview
Twist Bioscience Corporation, based in San Francisco, specializes in nucleic acid synthesis, offering innovative solutions for a range of applications including gene libraries and antibody optimization. The company leverages advanced technologies in polynucleotides and covalently closed nucleic acids to enhance research and development in biotechnology. Twist's expertise extends to digital information storage and hybridization methods, positioning it as a leader in the synthesis and assembly of genetic materials for various scientific and industrial purposes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Twist Bioscience Corporation USPTO Patent Assignee Logo
76 Patents

#71 in San Francisco, CA

#1,132 in California

#4,846 in US

#9,898 in the World

San Francisco, CA (US)
San Francisco, CA, United States of America

Twist Bioscience Corporation

Forward Citations = 1,202

41 inventors:

goldMedal Bill James Peck (37 out of 37 patents)

silverMedal Siyuan Chen (36 out of 41 patents)

bronzeMedal Pierre F Indermuhle (27 out of 51 patents)

4.  Andres Fernandez (26 out of 42 patents)

5.  William Banyai (23 out of 26 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Twist Bioscience Corporation. Retrieved from https://idiyas.com/company/twist-bioscience

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…